OBTURATING MEANS FOR CONTAINER FOR PHARMACEUTICAL AND MEDICAL PREPARATION

Abstract: The present invention relates to a modified obturating means for a container or a syringe intended to contain a pharmaceutical or medical preparation. The present invention relates also to a process for treating obturating means prepared at least from one elastomeric material, in which at least the elastomeric part of the obturating means is at least partially subjected to a treatment with elementary halogen or chemical compound(s) containing reactive halogen.

Description: Obturating means for container for pharmaceutical and medical preparation ABSTRACT OF THE DISCLOSURE The present invention relates to an obturating means prepared at least from one elastomeric material, said means being intended for a static and/or dynamic seal of a container intended to contain a pharmaceuti¬ cal or medical preparation, in which at least the elastomeric part of the obturating means is at least partially subjected to a treatment with elementary halogen or chemical compound(s) containing reactive halogen atoms so that said obturating means has at least the following properties : - ability to form at least a static gas- and liquidtight seal for the container ; . - very low release of extraneous material to the pharmaceutical or medical preparation of the container; - compatibility with pharmaceutical or medical preparation ; - ability to support currently practiced technical treatments for surface cleaning and sterilization ; - ability to be processed in current technical container filling and closing equipment. The present invention relates among others to a container provided with such an obturating means and to a syringe comprising a slidable obturating means acting as a stopper. The present invention relates also to a process for treating obturating means prepared at least from one elastomeric material, said means being intended for a static or dynamic seal of a container intended to contain a pharmaceutical or medical preparation, in which at least the elastomeric part of the obturating means is at least partially subjected to a treatment with elementary halogen or chemical compound(s) containing reactive halogen. THE PRIOR ART The preparation of materials for pharmaceutical and medical use requires the utmost care. Such materials may be used for medication of humans or animals , as well as for various related purposes , such as the diagnosis of disorders of humans and animals. If the materials deviate from the required quality standard, they may exert obnoxious or even fatal influence on the treated being or lead to equally dangerous wrong conclusions in for instance a diagnosis . The preparation of such materials is entrusted to qualified pharmacists. They generate the materials in the required quality by using appropriate equipment and procedures in carefully constructed premises . The materials, once prepared, must however be stored in containers in order to allow their transport to the application site. Between preparation and application, a considerable time interval may elapse. It is clear that the container must be such that no appreciable deterioration of the materials takes place. Container systems for the purpose of storage of the materials have been elaborated in the past three or four decades for a very large number of applications . In many cases , the container system not only preserves the good quality of the packed material but additionally facilitates or even makes possible its actual application. Many systems employ elastomeric (rubber) components, functioning practically always as a sealing means between the container content and the environment, and additionally also in many cases as a means for easy and/or safe application. Two typical examples from a very large body are the following : 1. A glass vial containing a fluid intended for parenteral medication is closed with a soft elastomeric stopper. The stopper allows penetration with a hypodermic needle or a spike. The sterile fluid may then be withdrawn from the vial without actually opening it, thus avoiding the danger of contamination with microorganisms or other undesirable matter. 2. A glass tube is used as a parenteral fluid cartridge by closing one end with an elastomeric stopper in the shape of a plunger. The other end is connected to a hypodermic needle. The fluid content of the cartridge can be pushed out through the needle by pushing the elastomeric plunger with a suitable plunger rod. In this application, the elastomeric part must form a static seal during shelf life of the cartridge and a dynamic seal during the actual application. In the latter stage, it must slide very smoothly in order to allow correct medical action. From the above, it will be clear that elastomeric seals in this area may have a very wide variety of shapes and dimensions. In the following text they will be adressed as "elastomeric seals" for short. In the course of the last three decades , much work has been devoted to the development of suitable materials for elastomeric seals in this field. The work was complex because elastomeric materials for the production of seals are composed themselves over " a number of starting materials. Such starting materials must be most carefully selected as well as combined in accurately balanced ratios in order to obtain seals possessing a complex of properties required for the application. Said seals having - the ability to form a static, and if required, dynamic gas- and liquidtight seal for a container containing pharmaceutical or medical preparation (1), - very low, and indeed pharmaceutically accepta¬ ble, release of extraneous material to the pharmaceuti- cal or medical preparation ( 2 ) , and - durability or persistance of the required properties during the storage time of the container with a pharmaceutical or medical preparation (3), must additionally have, in order to be suitable to be used in equipment for filling or closing containers , the following properties : - ability to support currently practiced technical treatments for surface cleaning and sterilization (4), and - ability to be processed in current technical container filling and closing equipment (5). By selecting suitable elastomeric base materials and further components , compounds may be obtained which, after curing in an appropriate shaping treatment, have a good balance of properties (1), (2) and (3) . Such compounds are proprietary to the pharmaceutical rubber industry. It has been observed that their final processing, especially on a large scale, in fast running modern machines, requires a certain adaptation of their surface state. By their nature, elastomeric objects have a relatively high coefficient of friction, for instance 2.4. This hampers their ability to be transported in filling equipment and similar machinery and, as a consequence, such equipment must be a'dapted in complicated and mostly costly ways. In order to overcome this problem, the elastomeric seals in many cases are coated with some lubricant, for instance silicone oil. Such treatment is additionally favourable in preventing ' the seals from sticking to one another, which also is a frequently observed phenomenon in uncoated seals , especially after treatment in cleaning, cleansing, sterilization and drying equipment. However, the silicone oil or other lubricant spoils some desirable properties of the seals : as an extraneous material, it contaminates the pharmaceutical or medical material stored in the container. In the case of silicone oil, for instance, it has been observed that a water-based medical preparation after contact with the silicone oil treated elastomeric seal, contains a relatively large quantity of silicone oil droplets in emulsified state. Coatings with various materials have been proposed, but they generally involve the already mentioned or other drawbacks, for instance a decreased sealing capacity or a high application cost. The present invention purports to resolve the problem by applying a relatively simple and at the same time cost-efficient treatment, consisting of introducing in a carefully controlled way an amount of halogen atoms into the seal surface. The treated seals acquire the necessary low friction coefficient and lose their aggregation tendency, even upon stringent cleaning, cleansing, sterilizing and drying treatment. They do not lose the desirable properties they already possess before the treatment and release a very low amount of extraneous material to a pharmaceutical or medical preparation. BRIEF DESCRIPTION OF THE INVENTION The invention relates to an obturating means prepared at least from one elastomeric material, said means being intended for a static and/or dynamic seal of a container intended to contain a pharmaceutical or medical preparation, in which at least the elastomeric part of the obturating means is at least partially subjected to a treatment with elementary halogen or chemical compound(s) containing reactive halogen atoms so that said obturating means has at least the following properties : - ability to form at least a static gas- and liquidtight seal for the container ; - very low release of extraneous material to the pharmaceutical or medical preparation ; - compatibility with the pharmaceutical or medical preparation ; - ability to support currently practiced technical treatments for surface cleaning and sterilization and - ability to be processed in current technical container filling and closing equipment. The obturating means according to the invention is preferably treated with fluorine. In an embodiment of the obturating means according to the invention, the elastomeric part thereof is at least partially treated with a fluorine gas after being washed. A preferred obturating means according to the invention is obtained by treating the elastomeric part thereof with fluorine gas under a pressure of at least 5 10 Pa, preferably under a pressure comprised between 10 5 and 5.105 Pa, during at least 60 seconds, preferably from 60 to 900 seconds, and at a temperature comprised between 15 and 25°C. The fluorine gas is advantageously mixed with an inert gas and preferably with nitrogen. Such a mixture contains, for example, 1 to 10 % fluorine gas and 90 to 99 % nitrogen gas. The invention relates also to - a container intended for pharmaceutical or medical preparation, said container being provided with an obturating means according to the invention, and - a syringe intended for the injection of pharmaceuti¬ cal or medical preparation, said syringe containing a slidable obturating means according to the invention, said means acting as a stopper. The invention relates also to a process for treating obturating means prepared from at least one elastomeric material, said means being intended for a static or dynamic seal of a container for pharmaceuti¬ cal or medical preparation. In said process, at least the elastomeric part of the obturating means is at least partially subjected to a treatment with elementary halogen or chemical compound(s) containing reactive halogen so as to obtain an obturating means according to the invention. Rubber obturating means according to the invention as well as a process according to the invention will be described hereafter with reference to the attached drawings which show embodiments of obturating means according to the invention. BRIEF DESCRIPTION OF THE DRAWINGS : figure 1 is a cross-sectional view of a vulca¬ nized obturating means according to the invention ; - figure 2 is a partial cross-sectional view of a vial provided with a vulcanized obturating stopper and figure 3 is a cross-sectional side view of a slidable stopper of a syringe, together with the syringe itself. DESCRIPTION OF THE INVENTION Obturating means according to the invention are prepared from at least one elastomeric material. Obturating means according to the invention are for example elastomeric stoppers for containers with a pharmaceutical or medical preparation or elastomeric slidable stoppers of syringes intended for injecting pharmaceutical or medical preparation. Rubber is the generic name for a class of materials composed essentially of one or more elastomeric materials such as polyisoprene, copolymer of isobutene and isoprene, copolymer of butadiene and acrylonitrile, polydimethylsiloxane. Said elastomeric materials may contain functional atoms or molecule groups, introduced before or after the polymerization. Non-elastomeric substances may be added to the elastomer in order to tailor the properties of the material to specific needs. Such substances are for instance finely powdered and purified minerals (example : bentonite clay), reactive chemicals intended to enable a crosslinking chemical reaction in the material after it has been converted into the desired shape. During the manufacturing process (information thereon is given for example in Rubber Technology and Manufacture edited by CM. BLOW published for the Institution of the Rubber Industry - BUTTERWORTHS LONDON - 1971), the various components for a given material are mixed to give a malleable compound. This compound is then converted into the desired shape. The material of the final product is characterized by the fact that it is capable of recovering from large deformations quickly and forcibly. It will retract within 1 minute to less than 1.5 times its original length after being stretched at room temperature ( 18 to 29 C C) to twice its length and held for 1 minute before release. The following table gives an example of composition of rubber : % by weight chlorobutyl rubber 50 to 55 vulcanizing agent 0.5 to 2 filler (silicate) 40 to 45 zinc oxide 1 to 3 stearine acid 0.5 to 2 paraffine oil 0.5 to 2 colorant (iron-, titane oxide) 0 to 2 polyethylene wax 0.5 to 3 The process according to the invention may be applied to obturating means composed of at least rubber or elastomeric material as described in the following examples, given as examples only. EXAMPLE 1 Said process comprised the following steps : 1. The obturating means were washed in a rotary drum, first with warm water and a neutral detergent, then with filtered water and finally with pyrogen-free water. 2. The obturating means were then dried by means of hot filtered air. 3. The obturating means were contacted in a rotary drum with fluorine which was mixed with nitrogen- The mixture of gases contained 1 % fluorine and 99 % volume nitrogen. The contact time of the obturating means with fluorine was 900 seconds. The obturating means were contacted with said mixture of gases at a temperature of 25°C and under 5 a pressure of 5.10 Pa. 4. The obturating means were washed with water and dried with hot filtered air. EXAMPLE 2 Said process comprised the following steps : 1. The obturating means were washed in a rotary drum, first with warm water and a neutral detergent, then with filtered water and finally with pyrogen-free water. ■ 2. The obturating means were then dried by means of hot filtered air. 3. The obturating means were contacted in a rotary drum with fluorine which was mixed with nitrogen. The mixture of gases contained 10 % fluorine and 90 % volume nitrogen. The contact time of the obturating means with fluorine was 60 seconds . The obturating means were contacted with said mixture of gases at a temperature of 15°C and under 5 a pressure of 10 Pa. 4. The obturating means were washed with water and dried with hot filtered air. Due to the fluorination of the vulcanized rubber product, for example a stopper 1, it is possible with the process according to the invention to obtain a product which has at least one surface 2 which has at least partially been chemically modified up to a certain depth, said depth being at least 10 nanometers —8 (10 m) and having a low friction coefficient and a low aggregation tendency, and which at most may cause a low particles contamination of pharmaceutical or medical materials in contact therewith. The following table lists typical values and observations deducted from a body of experimental findings and demonstrating the effectiveness of the treatment according to the invention. TABLE 1 cm of rubber surface was in contact with 2 ml of particle free water. ** determined in comparable circumstances . The table shows that the contamination due to the vulcanized rubber treated by the process according to the invention is 100 times lower than the conta¬ mination due to rubber covered with a silicone layer. The man skilled in the art was not able to predict that it was possible to obtain obturating means having the following properties : - ability to form at least a static, preferably a static and dynamic, gas- and liquidtight seal for the container ; - very low release of extraneous material to the pharmaceutical or medical preparation as exemplified in the table ; - compatibility with pharmaceutical or medical preparation ; - ability to support currently practiced technical treatments for surface cleaning and sterilization, and - ability to be processed in current technical container filling and closing equipment ; only by treating the obturating means according to the invention. The man skilled in the art who tried to avoid contamination of pharmaceutical or medical preparation with particles of the obturating means had the preconceived idea that it was necessary to add a coating on the obturating means so as to make a barrier between the obturating means and the pharma¬ ceutical or medical preparation. (For example, see European patent application 0 264 273 or US patent 4 808 453) . Figure 2 shows a vial 3 which is provided with an opening 4 which is sealed by a stopper 5 made of rubber and treated by the process according to the invention. Said vial is suitable for containing pharmaceuticals , for example cephalosporine. The sealing of opening 4 is perfect since the fluorinated surface 2 takes the form of the opening 4 and since said surface 2 consists of a homogeneous and regular layer which is strongly bonded to the stopper. Figure 3 shows a rubber stopper 6 for sealing a syringe 7 which may be previously filled with a pharmaceutical or which may be used for extracting a pharmaceutical from a vial and for injecting it to a patient. The fluorinated surface of said stopper 6 allows that only a low working force has to be exerted on the stopper during the injection. This force is not increased after storing, for example, a syringe filled 3 years before using it. Due to the absence of silicones which previously were necessary in order to guarantee the sliding of the stopper, there is no more contamination of the pharmaceutical with particles . Due to the fact that the surface of the rubber products treated by the process according to the invention is more hydrophobic, there is less inter¬ action between the rubber and the pharmaceuticals which are in contact therewith. The transfer of rubber ingredients to the pharmaceuticals is thereby reduced so that the rubber products according to the invention have a better compatibility. The surface 2 of rubber products treated by the process according to the invention has a repelling force for dust so that said dust is not able to be deposited on said surface 2. Said dust is thus not able to contaminate the stopper 5 even if said stopper is stored in an environment slightly contaminated with particles during a long time. In the obturating means according to the invention, a part thereof may not be subjected to a treatment with elementary halogen or chemical compound(s) containing reactive halogen atoms, said means being provided with an untreated surface which is not intended to be in contact with a pharmaceutical or medical preparation.

Claims: What we claim is : 1. Obturating means prepared at least from one elastomeric material, said means being intended for a static and/or dynamic seal of a container intended to contain a pharmaceutical or medical preparation, in which at least the elastomeric part of the obturating means is at least partially subjected to a treatment with elementary halogen or chemical compound(s) containing reactive halogen atoms so that said obturating means has at least the following properties : - ability to form at least a static gas- and liquidtight seal for the container ; - very low and pharmaceutically acceptable release of extraneous material to the container content ; - compatibility with pharmaceutical or medical preparation ; - ability to support currently practiced technical treatments for surface cleaning and sterilization, and - ability to be processed in current technical container filling and closing equipment. 2. Obturating means according to claim 1, in which the halogen is fluorine. 3. Obturating means according to claim 1 or 2, in which the elastomeric part of obturating means is at least partially treated with a fluorine gas . 4. Obturating means according to one of the preceed- ing claims , in which the elastomeric part thereof is at least partially washed before being treated with a halogen. 5. Obturating means according to one of the preceed- ing claims , in which the elastomeric part thereof is treated with fluorine gas under a pressure of at least 5 10 Pa ( 1 atm) during at least 60 seconds. 6. Obturating means according to one of the preceed- ing claims , in which the elastomeric part thereof is treated with fluorine gas under a pressure comprised between 10 5 and 5.10 5 Pa (1 and 5 atm) during 60 to 900 seconds at a temperature comprised between 15 and 25°C. 7. Obturating means according to one of the preceed- ing claims , in which the elastomeric part thereof is at least partially treated with a mixture of fluorine gas and an inert gas . 8. Obturating means according to claim 7, in which the elastomeric part thereof is at least partially treated with a mixture containing from 1 to 10 % of fluorine gas and from 90 to 99 % of nitrogen gas. 9. Obturating means according to one of the preceed- ing claims, in which at least one surface (2) has at least partially been chemically modified up to —8 a certain depth, said depth being at least 10 meter. 10. Container intended for a pharmaceutical or medical preparation, said container being provided with an obturating means according to one of the preceeding claims . 11. Syringe intended for the injection of a pharmaceutical or medical preparation, said syringe containing a slidable obturating means according to one of the claims 1 to 9, said means acting as a stopper. 12. Process for treating obturating means prepared at least from one elastomeric material, said means being intended for a static or dynamic seal of a container intended to contain a pharmaceutical or medical .preparation, in which at least the elastomeric part of the obturating means is at least partially subjected to a treatment with elementary halogen or chemical com¬ pound^) containing reactive halogen so as to obtain an obturating means according to one of the claims 1 to 9. 13. Process according to claim 12, in which the halogen is fluorine. 14. Process according to claim 12 or 13, in which the elastomeric part of the obturating means is at least partially treated with a fluorine gas so that the number of particles having a size equal to or greater than 2 microns per ml of the contact fluid (water) which are liberated therein at a temperature of 121°C during 30 minutes is lower than about 500, the 2 rruubbbbeerr surface being of 1 cm for 2 ml of contact fluid. 15. Process according to one of the claims 12 to 14, in which a mixture of fluorine gas and of an inert gas is used for the treatment of at least an elastomeric part of the obturating means .

Inventors: THIJS ANITA, VAN DE POEL WILLY, THIJS, ANITA, VAN DE POEL, WILLY
Applicants: HELVOET PHARMA, HELVOET PHARMA N.V.
Application year: 1989
Main classification: C08J7
IPC codes: A61J1, A61M5, B65D51, B65D53, C08J7